Coherus Appoints Juliana M. Reed, Vice President, Government Affairs

REDWOOD CITY, Calif., Sept. 9, 2015 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Nasdaq:CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, today is pleased to announce the appointment of Juliana M. Reed as Vice President, Government Affairs. Ms. Reed joins Coherus with over 10 years in government affairs, specializing in global biosimilars policy.

“We welcome Juliana to the Coherus team,” said Denny Lanfear, President and Chief Executive Officer of Coherus. “Juliana is an accomplished executive who brings a wealth of experience, insight and leadership in the development of government policies that impact this new industry. The Coherus leadership team is composed of successful veterans who have helped pioneer the biologics industry. With the addition of Juliana, we now have one of the recognized leading experts on global biosimilar public policy. We look forward to working with Juliana in our efforts towards bringing affordable medications to patients and creating a vibrant marketplace for biosimilars in the US.”

“I am thrilled to join Coherus,” said Ms. Reed. “The team is driven by a common mission and passion to expand patient access to important medicines by developing biosimilars to biologics that have been on markets for years. It is an honor and a privilege to join them on this mission.”

Ms. Reed has extensive experience in governmental and public affairs in the healthcare, pharmaceutical and medical device industries, including roles with Baxter and Hospira. Juliana led the development and execution of the Hospira global biosimilars public policy strategy for the last 10 years, prior to the recent Pfizer acquisition of Hospira. Juliana is the current President of the Biosimilars Forum, a not for profit group representing the US biosimilars industry. The members of the Biosimilars Forum represent the largest pipeline of biosimilars in development in the US. Juliana earned her BS from Marquette University and her MS from DePaul University.

Insurance company LifeMap taps Wildflower for pregnancy app

San Francisco-based digital health startup Wildflower Health partnered with health insurance company LifeMap Assurance to launch an app, called LifeMap Due Date Plus, for expectant parents with short term disability coverage. The app is available on iOS and Android devices.

“LifeMap is an ancillary benefits provider meaning that they provide things like disability benefits, insurance benefits, and dental benefits to employers,” Wildflower CEO Leah Sparks told MobiHealthNews. “And, what’s interesting about them is that — the number one reason for short term disability is typically maternity.
So in the implementation we’re doing with LifeMap, it’s a little bit different than some of the other customers where we might focus on the medical intervention. It’s really about helping women navigate some of the things to do with taking time off work, tapping into their disability coverage, which is just as top of mind when women are navigating pregnancy as the healthcare piece. It’s a really nice and neat point of synergy between what we offer in Due Date Plus and what LifeMap offers.”

“LifeMap is an ancillary benefits provider meaning that they provide things like disability benefits, insurance benefits, and dental benefits to employers,” Wildflower CEO Leah Sparks told MobiHealthNews. “And, what’s interesting about them is that — the number one reason for short term disability is typically maternity. So in the implementation we’re doing with LifeMap, it’s a little bit different than some of the other customers where we might focus on the medical intervention. It’s really about helping women navigate some of the things to do with taking time off work, tapping into their disability coverage, which is just as top of mind when women are navigating pregnancy as the healthcare piece. It’s a really nice and neat point of synergy between what we offer in Due Date Plus and what LifeMap offers.”

PCI | HealthDev Announces New COO

July 22, 2015, Dallas, TX – PCI | HealthDev® (“HealthDev”)/ the Company), a leader in medical real estate development and investment solutions, is pleased to announce the promotion of Jeff Kroll to Chief Operating Officer (COO). Jeff joined HealthDev in 2012 and previously was Senior Vice President, Business Development and Asset Financing, for the Company. Jeff will continue to be based in HealthDev’s Denver office. As COO, Jeff will be responsible for optimizing the cross-functional operations and performance of various departments within HealthDev, as well as spearheading the Company’s interactions with its clients. Jeff will directly oversee HealthDev’s Real Estate Development, Compliance and Operations, Legal, and Business Development departments. Jeff has more than 15 years of experience in real estate development and finance, and has performed a wide variety of activities related to acquisitions, development, asset management and dispositions in real estate. Prior to joining HealthDev, Jeff served as Vice President of Real Estate for Frontier Renewal, an urban-infill real estate company focused on redeveloping environmentally impaired properties for commercial and residential uses. Holding a Bachelor of Arts degree in Broadcast Journalism from the University of Colorado, and an MBA specializing in Real Estate Investment and Finance from the University of Denver, Jeff is an active member of numerous commercial real estate and healthcare professional organizations. Jeff is known for his ability to develop and foster trustworthy and long-lasting relationships with clients and translate their strategic and financial goals into effective real estate solutions. “Our rigorous standards for medical development, scalability, project transparency and compliance already set us apart from our competitors,” said Pedro Juan Vergne-Morell, CEO of HealthDev. “Jeff has proven himself to be a leader with unique expertise and talent. With the expansion of Jeff’s role, HealthDev is positioned for unprecedented growth in the development of new medical facilities while further deepening our already strong provider and physician relationships. We’re very happy that Jeff is taking on a greater role within our family.” The feeling is mutual – “HealthDev has an exceptional team in place and I am excited to help take the company to the next level,” said Jeff. “Our industry-leading capabilities and our ability to customize real estate solutions are the perfect combination for today’s growing and dynamic healthcare industry.” About HealthDev Founded in 2007 by Pedro Vergne-Marini, M.D., PCI | HealthDev® is owned and managed in-part by physicians, medical industry and real estate experts who understand the challenges and opportunities that exist today’s economy as well as the strategic and financial impacts created by healthcare reform legislation. HealthDev is committed to providing industry-leading solutions (via NuBuild℠ and AssetMax℠) to healthcare professionals and providers in order to help them achieve their short- and long-term financial and medical real estate needs and goals. HealthDev streamlines and simplifies financing, medical facility development, construction, and ownership and the management of the asset so physicians, hospitals and healthcare providers can focus on what they do best – delivering quality care. In addition to its Dallas headquarters located at 8117 Preston Rd., Suite 400, Dallas, TX 75225, PCI | HealthDev also maintains regional offices at 1225 Seventeenth St., Suite 1750, Denver, CO 80202 and 555 12th Street, Suite 2040 Oakland, CA 94607.